Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities
Net Income (Loss)	$ (3,500,079)	$ (1,800,356)
Adjustments to Reconcile Net (Loss) to Net Cash Used in Operating Activities
Depreciation & Amortization	112,026	13,159
Changes in Operating Assets and Liabilities
(Increase) in Other Receivable	(122,861)
Increase (Decrease) in Accounts Payable & Acrued Expenses	(624,221)	244,918
Increase (Decrease) in Accounts Payable - Related Parties	(60,000)	(12,006)
Increase (Decrease) in Accrued Interest	1,694,922	1,185,138
Net Cash Flows Used in Operating Activities	(2,500,213)	(369,147)
Cash Flows from Investing Activities
Leasehold Improvements and Other Assets	(142,372)	7,265
Advance on Business Acquisition	(350,000)	(310,188)
Net Cash (Used in) Provided by Investing Activities	(492,372)	(302,923)
Cash Flows from Financing Activities
Proceeds from Notes		174,815
Proceeds from Convertible Notes	759,300	525,812
Proceeds from Convertible Notes - Related Parties	2,231,292
Net Cash (Used in) Provided by Financing Activities	2,990,592	700,627
Net Increase (Decrease) in Cash and Cash Equivalents	(1,993)	28,557
Cash and Cash Equivalents, Beginning of Year	62,381	3,016
Cash and Cash Equivalents, End of Year	60,388	31,573
Supplemental Cash Flow Information
Interest	33,716
Income Taxes Paid
Accrued Expense Reclassified to Notes Payable	831,628	105,206
Accrued Interest Reclassified to Notes Payable		254,829
Construction in Progress Exchanged for Patent		1,096,816
Land Exchanged for Patent		1,064,651
Loans Payable Exchanged for Patent		202,663
Stock Issued in Exchange for Patent		3
Patent Acquired with Above Consideration		$ 2,364,133